SURG financial statements and SEC filings

SURG annual income statement

Fiscal period endRevenueOperating incomeNet incomeSEC filing
2025-12-31$56.96M-$34.14M-$36.07M10-K
2024-12-31$60.88M-$43.46M-$45.73M10-K
2023-12-31$137.14M$18.87M$20.62M10-K
2022-12-31$121.54M$633.78K-$680.76K10-K
2021-12-31$51.06M-$5.99M-$13.53M10-K
2020-12-31$54.41M-$10.15M-$10.72M10-K

SURG annual balance sheet

Fiscal period endAssetsLiabilitiesEquitySEC filing
2025-12-31$8.52M$23.92M-$15.40M10-Q
2024-12-31$23.98M$8.71M$15.26M10-K
2023-12-31$41.93M$13.52M$28.40M10-K
2022-12-31$34.00M$28.89M$5.12M10-K
2021-12-31$19.50M$15.95M$3.55M10-K
2020-12-31$7.33M$18.05M-$10.73M10-K

SURG annual cash flow

Fiscal period endOperating cash flowCapital expenditureFinancing cash flowSEC filing
2025-12-31-$21.29M-$18.59K$10.53M10-K
2024-12-31-$21.31M-$518.19K$22.48M10-K
2023-12-31$10.29M–-$2.42M10-K
2022-12-31$793.27K-$11.40K$1.46M10-K
2021-12-31-$15.29M-$51.41K$21.27M10-K
2020-12-31-$4.33M-$6.61K$4.65M10-K